Equity (Tables)
|
9 Months Ended |
Sep. 30, 2025 |
|---|
| Equity [Abstract] |
|
| Schedule of Share Activity |
The table below outlines the share activity for the nine months ended September 30, 2025 and 2024:
| | | | | | | | | | | | | | | Nine months ended September 30, | | 2025 | | 2024 | | | Shares of common stock issued in settlement of vested RSUs and options exercised1 | 8,493,885 | | | 7,352,428 | | | | Reduction of shares of common stock issued2 | (3,411,169) | | | (2,404,677) | | | | Shares of common stock purchased related to share issuances and forfeitures3 | — | | | (149,002) | | | | | Issuance of shares of common stock for equity-based awards | 5,082,716 | | | 4,798,749 | | | | | | | 1 The gross value of shares issued was $1,361 million and $789 million for the nine months ended September 30, 2025 and 2024, respectively, based on the closing price of the shares of common stock at the time of issuance. | 2 Cash paid for tax liabilities associated with net share settlement was $561 million and $310 million for the nine months ended September 30, 2025 and 2024, respectively. | 3 Certain Apollo employees receive a portion of the profit sharing proceeds of certain funds in the form of (a) restricted shares of common stock that they are required to purchase with such proceeds or (b) RSUs, in each case which equity-based awards generally vest over three years. These equity-based awards are granted under the Company's Equity Plan. To prevent dilution on account of these awards, Apollo may, in its discretion, repurchase shares of common stock on the open market and retire them. During the nine months ended September 30, 2024, Apollo issued 228,392 of such restricted shares and 149,002 of such RSUs under the Equity Plan, respectively. | |
|
| Schedule of Quarterly Dividends and Distributions |
Outlined below is information regarding quarterly dividends and distributions (in millions, except per share data).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Dividend Declaration Date | | Dividend per Share of Common Stock | | Payment Date | | Dividend to Common Stockholders | | | | | | Distribution Equivalents on Participating Securities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | February 8, 2024 | | $ | 0.43 | | | February 29, 2024 | | $ | 245 | | | | | | | $ | 14 | | | May 2, 2024 | | 0.46 | | | May 31, 2024 | | 263 | | | | | | | 16 | | | August 1, 2024 | | 0.46 | | | August 30, 2024 | | 262 | | | | | | | 15 | | | November 5, 2024 | | 0.46 | | | November 29, 2024 | | 262 | | | | | | | 15 | | | Year ended December 31, 2024 | | $ | 1.81 | | | | | $ | 1,032 | | | | | | | $ | 60 | | | February 4, 2025 | | $ | 0.46 | | | February 28, 2025 | | $ | 264 | | | | | | | $ | 14 | | | May 2, 2025 | | 0.51 | | | May 30, 2025 | | 292 | | | | | | | 14 | | | August 5, 2025 | | 0.51 | | | August 29, 2025 | | 291 | | | | | | | 15 | | | | | | | | | | | | | | | | Nine months ended September 30, 2025 | | $ | 1.48 | | | | | $ | 847 | | | | | | | $ | 43 | |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | | Unrealized investment gains (losses) on AFS securities with a credit allowance | | Unrealized gains (losses) on hedging instruments | | Remeasurement gains (losses) on future policy benefits related to discount rate | | Remeasurement gains (losses) on market risk benefits related to credit risk | | | | | | Foreign currency translation and other adjustments | | Accumulated other comprehensive income (loss) | | Balance at June 30, 2025 | $ | (7,384) | | | $ | (270) | | | $ | (26) | | | $ | 4,043 | | | $ | (115) | | | | | | | $ | 59 | | | $ | (3,693) | | | | | | | | | | | | | | | | | | | | | Other comprehensive income (loss) before reclassifications | 1,964 | | | (5) | | | 75 | | | (235) | | | (113) | | | | | | | (40) | | | 1,646 | | Less: Reclassification adjustments for gains (losses) realized1 | (90) | | | (1) | | | 8 | | | — | | | — | | | | | | | — | | | (83) | | | Less: Income tax expense (benefit) | 424 | | | 1 | | | 14 | | | (52) | | | (24) | | | | | | | (7) | | | 356 | | | Less: Other comprehensive income (loss) attributable to non-controlling interests, net of tax | 329 | | | (8) | | | 16 | | | (144) | | | (17) | | | | | | | (4) | | | 172 | | | Balance at September 30, 2025 | $ | (6,083) | | | $ | (267) | | | $ | 11 | | | $ | 4,004 | | | $ | (187) | | | | | | | $ | 30 | | | $ | (2,492) | | | | | | | | | | | | | | | | | | | | 1 Recognized in investment related gains (losses) on the condensed consolidated statements of operations. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | | Unrealized investment gains (losses) on AFS securities with a credit allowance | | Unrealized gains (losses) on hedging instruments | | Remeasurement gains (losses) on future policy benefits related to discount rate | | Remeasurement gains (losses) on market risk benefits related to credit risk | | Foreign currency translation and other adjustments | | Accumulated other comprehensive income (loss) | | Balance at June 30, 2024 | $ | (9,674) | | | $ | (277) | | | $ | (82) | | | $ | 4,218 | | | $ | 5 | | | $ | (10) | | | $ | (5,820) | | | | | | | | | | | | | | | | | Other comprehensive income (loss) before reclassifications | 5,143 | | | (22) | | | 225 | | | (2,263) | | | (93) | | | 61 | | | 3,051 | | Less: Reclassification adjustments for gains (losses) realized1 | (348) | | | (8) | | | 4 | | | — | | | — | | | — | | | (352) | | | Less: Income tax expense (benefit) | 1,122 | | | (3) | | | 47 | | | (472) | | | (20) | | | 8 | | | 682 | | | Less: Other comprehensive income (loss) attributable to non-controlling interests, net of tax | 886 | | | 7 | | | 60 | | | (596) | | | (9) | | | 26 | | | 374 | | | Balance at September 30, 2024 | $ | (6,191) | | | $ | (295) | | | $ | 32 | | | $ | 3,023 | | | $ | (59) | | | $ | 17 | | | $ | (3,473) | | | | | | | | | | | | | | | | 1 Recognized in investment related gains (losses) on the condensed consolidated statements of operations. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | | Unrealized investment gains (losses) on AFS securities with a credit allowance | | Unrealized gains (losses) on hedging instruments | | Remeasurement gains (losses) on future policy benefits related to discount rate | | Remeasurement gains (losses) on market risk benefits related to credit risk | | Foreign currency translation and other adjustments | | Accumulated other comprehensive income (loss) | | | | Balance at December 31, 2024 | $ | (9,174) | | | $ | (284) | | | $ | (119) | | | $ | 4,235 | | | $ | (103) | | | $ | (49) | | | $ | (5,494) | | | | | | | | | | | | | | | | | | | | | Other comprehensive income (loss) before reclassifications | 4,560 | | | 26 | | | 315 | | | (808) | | | (132) | | | 184 | | | 4,145 | | | | Less: Reclassification adjustments for gains (losses) realized1 | (358) | | | (4) | | | 27 | | | — | | | — | | | — | | | (335) | | | | | Less: Income tax expense (benefit) | 1,004 | | | 6 | | | 60 | | | (168) | | | (28) | | | 21 | | | 895 | | | | | Less: Other comprehensive income (loss) attributable to non-controlling interests, net of tax | 823 | | | 7 | | | 98 | | | (409) | | | (20) | | | 84 | | | 583 | | | | | Balance at September 30, 2025 | $ | (6,083) | | | $ | (267) | | | $ | 11 | | | $ | 4,004 | | | $ | (187) | | | $ | 30 | | | $ | (2,492) | | | | | | | | | | | | | | | | | | | | 1 Recognized in investment related gains (losses) on the condensed consolidated statements of operations. | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | | Unrealized investment gains (losses) on AFS securities with a credit allowance | | Unrealized gains (losses) on hedging instruments | | Remeasurement gains (losses) on future policy benefits related to discount rate | | Remeasurement gains (losses) on market risk benefits related to credit risk | | Foreign currency translation and other adjustments | | Accumulated other comprehensive income (loss) | | Balance at December 31, 2023 | $ | (8,675) | | | $ | (289) | | | $ | (81) | | | $ | 3,458 | | | $ | 3 | | | $ | 9 | | | $ | (5,575) | | | | | | | | | | | | | | | | | Other comprehensive income (loss) before reclassifications | 3,528 | | | (19) | | | 264 | | | (832) | | | (87) | | | 22 | | | 2,876 | | Less: Reclassification adjustments for gains (losses) realized1 | (237) | | | (14) | | | 35 | | | — | | | — | | | — | | | (216) | | | Less: Income tax expense (benefit) | 776 | | | (1) | | | 49 | | | (176) | | | (18) | | | 4 | | | 634 | | | Less: Other comprehensive income (loss) attributable to non-controlling interests, net of tax | 505 | | | 2 | | | 67 | | | (221) | | | (7) | | | 10 | | | 356 | | | Balance at September 30, 2024 | $ | (6,191) | | | $ | (295) | | | $ | 32 | | | $ | 3,023 | | | $ | (59) | | | $ | 17 | | | $ | (3,473) | | | | | | | | | | | | | | | | 1 Recognized in investment related gains (losses) on the condensed consolidated statements of operations. |
|